1. 172 Differential markers and in vitro function of SLE patient sera autoantibodies in a large cohort reveals specific activation of nucleic-acid sensing pathways. (April 2019) Authors: Hawtin, Stuart R; Andre, Cedric; Caballero, Valerie; McMichael, Katriona; Pfister, Sabina; Appenzeller, Simone; Watts, Allen; Rush, James; Brunner, Hermine I Journal: Lupus science & medicine Issue: Volume 6(2019)supplement 1 Page Start: A131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0174 SUBCUTANEOUS DOSING OF THE NOVEL ANTI-CD40 ANTIBODY ISCALIMAB ACHIEVES TARGET DRUG EXPOSURE AND CLINICAL EFFICACY IN PRIMARY SJÖGREN'S SYNDROME; RESULTS OF A PHASE IIA RANDOMISED OPEN LABEL TWO ARM PARALLEL GROUP TRIAL. (June 2019) Authors: Fisher, Benjamin; Szántó, Antónia; Ng, Wan Fai; Bombardieri, Michele; Posch, Maximilian; Papas, Athena; Farag, Arwa; Daikeler, Thomas; Bannert, Bettina; Kivitz, Alan; Carsons, Steven; Isenberg, David; Barone, Francesca; Bowman, Simon J.; Espie, Pascal; Wieczorek, Grazyna; Moulin, Pierre; Floch, D... Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 760 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗